Sale!

PSEN2 Gene Alzheimer disease type 4 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PSEN2 Gene Alzheimer’s Disease Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PSEN2 gene, which are linked to the development of Alzheimer’s disease type 4. This form of Alzheimer’s disease is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to increase an individual’s risk of developing the condition. The test is crucial for individuals with a family history of Alzheimer’s disease, as it can provide valuable insights into their genetic predisposition to this type of dementia.

The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PSEN2 gene that are associated with Alzheimer’s disease type 4. The results of this test can help individuals make informed decisions about their health and lifestyle, and in some cases, may lead to the consideration of preventative measures or early interventions.

The cost of the PSEN2 Gene Alzheimer’s Disease Type 4 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specific expertise required to conduct and interpret the test, this price reflects the comprehensive service provided, including the genetic counseling that is often recommended to discuss the results and their implications for the individual and their family members.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PSEN2 Gene Alzheimer Disease Type 4 Genetic Test

At DNA Labs UAE, we offer the PSEN2 Gene Alzheimer Disease Type 4 Genetic Test to help diagnose early-onset familial Alzheimer’s disease (EOFAD) caused by mutations in the PSEN2 gene. This test can be a valuable tool for individuals with a family history of early-onset Alzheimer’s disease or those experiencing symptoms at a young age.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the PSEN2 Gene Alzheimer Disease Type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PSEN2 Gene Alzheimer Disease Type 4.

Test Details

The PSEN2 gene is one of three genes associated with EOFAD. Mutations in this gene are responsible for Alzheimer’s disease type 4 (AD4), which accounts for a small proportion of all Alzheimer’s cases. Our NGS genetic testing utilizes Next Generation Sequencing technology to analyze multiple genes simultaneously, allowing us to identify mutations in the PSEN2 gene.

It is important to note that not all individuals with a mutation in the PSEN2 gene will develop Alzheimer’s disease, and not all cases of Alzheimer’s disease are caused by mutations in this gene. Therefore, genetic testing should be used in conjunction with other diagnostic tools to accurately diagnose Alzheimer’s disease.

Test Name PSEN2 Gene Alzheimer disease type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PSEN2 Gene Alzheimer disease type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN2 Gene Alzheimer disease type 4
Test Details

The PSEN2 gene is one of three genes associated with early-onset familial Alzheimer’s disease (EOFAD). Mutations in this gene are responsible for Alzheimer’s disease type 4 (AD4), which accounts for a small proportion of all Alzheimer’s cases.

NGS (Next Generation Sequencing) genetic testing is a type of DNA sequencing that can analyze multiple genes at once, making it a useful tool for identifying mutations in the PSEN2 gene. This test can be used to diagnose AD4 in individuals who have a family history of early-onset Alzheimer’s disease or who have symptoms of the disease at a young age.

However, it is important to note that not all individuals with a mutation in the PSEN2 gene will develop Alzheimer’s disease, and not all cases of Alzheimer’s disease are caused by mutations in this gene. Therefore, genetic testing should be used in combination with other diagnostic tools to accurately diagnose Alzheimer’s disease.